These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 7888091)
1. Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism. Charlton CG; Mack J Mol Neurobiol; 1994; 9(1-3):149-61. PubMed ID: 7888091 [TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa. Charlton CG; Crowell B Pharmacol Biochem Behav; 1992 Oct; 43(2):423-31. PubMed ID: 1359575 [TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism. Charlton CG; Crowell B Mol Chem Neuropathol; 1995 Dec; 26(3):269-84. PubMed ID: 8748929 [TBL] [Abstract][Full Text] [Related]
4. Depletion of nigrostriatal and forebrain tyrosine hydroxylase by S-adenosylmethionine: a model that may explain the occurrence of depression in Parkinson's disease. Charlton CG Life Sci; 1997; 61(5):495-502. PubMed ID: 9247319 [TBL] [Abstract][Full Text] [Related]
5. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease. Wang X; Yang HA; Wang XN; Du YF Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats. Lee ES; Soliman KF; Charlton CG Neurotoxicology; 2005 Jan; 26(1):27-38. PubMed ID: 15527871 [TBL] [Abstract][Full Text] [Related]
7. Excessive S-adenosyl-L-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: possible role in S-adenosyl-L-methionine-induced Parkinson's disease-like disorders. Lee ES; Chen H; Hardman C; Simm A; Charlton C Life Sci; 2008 Dec; 83(25-26):821-7. PubMed ID: 18930743 [TBL] [Abstract][Full Text] [Related]
8. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079 [TBL] [Abstract][Full Text] [Related]
9. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932 [TBL] [Abstract][Full Text] [Related]
10. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa. Liu XX; Wilson K; Charlton CG Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949 [TBL] [Abstract][Full Text] [Related]
11. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors. Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495 [TBL] [Abstract][Full Text] [Related]
12. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease. González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990 [TBL] [Abstract][Full Text] [Related]
13. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314 [TBL] [Abstract][Full Text] [Related]
14. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers. Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399 [TBL] [Abstract][Full Text] [Related]
15. Age-related dopamine deficiency in the mesostriatal dopamine system of zitter mutant rats: regional fiber vulnerability in the striatum and the olfactory tubercle. Ueda S; Aikawa M; Ishizuya-Oka A; Yamaoka S; Koibuchi N; Yoshimoto K Neuroscience; 2000; 95(2):389-98. PubMed ID: 10658618 [TBL] [Abstract][Full Text] [Related]
16. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra. von Bohlen und Halbach O; Minichiello L; Unsicker K FASEB J; 2005 Oct; 19(12):1740-2. PubMed ID: 16037097 [TBL] [Abstract][Full Text] [Related]
17. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion. Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350 [TBL] [Abstract][Full Text] [Related]
18. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Bukhatwa S; Zeng BY; Rose S; Jenner P Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003 [TBL] [Abstract][Full Text] [Related]
19. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease]. Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380 [TBL] [Abstract][Full Text] [Related]
20. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease. Duda J; Pötschke C; Liss B J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]